267 related articles for article (PubMed ID: 25870161)
21. [Direct oral thrombin inhibitor, "dabigatran"].
Yasaka M
Nihon Rinsho; 2013 Jan; 71(1):113-8. PubMed ID: 23631181
[TBL] [Abstract][Full Text] [Related]
22. Public health. Change of heart.
Taylor J
Health Serv J; 2012 Jul; 122(6315):19-20. PubMed ID: 23155563
[No Abstract] [Full Text] [Related]
23. Novel oral anticoagulants for stroke prevention in patients with atrial fibrillation.
Berman JP; Halperin JL
Hosp Pract (1995); 2013 Feb; 41(1):37-48. PubMed ID: 23466966
[TBL] [Abstract][Full Text] [Related]
24. Stroke prevention in atrial fibrillation.
Wagenaar P
Cardiovasc J Afr; 2011; 22(2):105. PubMed ID: 21556458
[No Abstract] [Full Text] [Related]
25. Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack.
Coleman CI; Peacock WF; Bunz TJ; Alberts MJ
Stroke; 2017 Aug; 48(8):2142-2149. PubMed ID: 28655814
[TBL] [Abstract][Full Text] [Related]
26. Assessing the impact of dabigatran and warfarin on health-related quality of life: results from an RE-LY sub-study.
Monz BU; Connolly SJ; Korhonen M; Noack H; Pooley J
Int J Cardiol; 2013 Oct; 168(3):2540-7. PubMed ID: 23664436
[TBL] [Abstract][Full Text] [Related]
27. Myocardial ischemic events in 'real world' patients treated with dabigatran.
Shah R
Am J Med; 2014 Oct; 127(10):e19. PubMed ID: 25311071
[No Abstract] [Full Text] [Related]
28. New evidences for old concerns with oral anticoagulation in atrial fibrillation: focus on dabigatran.
Barrios V; Escobar C
Expert Opin Pharmacother; 2012 Dec; 13(18):2649-61. PubMed ID: 23167273
[TBL] [Abstract][Full Text] [Related]
29. Dabigatran - neurosurgical anathema?
Thomas PA; Schaerf NB; Rosenfeld JV
Med J Aust; 2013 Aug; 199(4):238-40. PubMed ID: 23984772
[No Abstract] [Full Text] [Related]
30. New oral anticoagulants in heart failure.
Van Gelder IC; Van Veldhuisen DJ; Lip GY
Eur J Heart Fail; 2013 Sep; 15(9):966-73. PubMed ID: 23960085
[No Abstract] [Full Text] [Related]
31. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation.
Freeman JV; Zhu RP; Owens DK; Garber AM; Hutton DW; Go AS; Wang PJ; Turakhia MP
Ann Intern Med; 2011 Jan; 154(1):1-11. PubMed ID: 21041570
[TBL] [Abstract][Full Text] [Related]
32. Economic appraisal of dabigatran as first-line therapy for stroke prevention in atrial fibrillation.
Bergh M; Marais CA; Miller-Jansön H; Salie F; Stander MP
S Afr Med J; 2013 Feb; 103(4):241-5. PubMed ID: 23547700
[TBL] [Abstract][Full Text] [Related]
33. Cost-effectiveness of dabigatran compared with warfarin for patients with atrial fibrillation in Sweden.
Davidson T; Husberg M; Janzon M; Oldgren J; Levin LÅ
Eur Heart J; 2013 Jan; 34(3):177-83. PubMed ID: 22733833
[TBL] [Abstract][Full Text] [Related]
34. Stroke prophylaxis with warfarin or dabigatran for patients with non-valvular atrial fibrillation-cost analysis.
Ali A; Bailey C; Abdelhafiz AH
Age Ageing; 2012 Sep; 41(5):681-4. PubMed ID: 22378612
[TBL] [Abstract][Full Text] [Related]
35. Myocardial ischemic events in patients with atrial fibrillation treated with dabigatran or warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial.
Hohnloser SH; Oldgren J; Yang S; Wallentin L; Ezekowitz M; Reilly P; Eikelboom J; Brueckmann M; Yusuf S; Connolly SJ
Circulation; 2012 Feb; 125(5):669-76. PubMed ID: 22215856
[TBL] [Abstract][Full Text] [Related]
36. Is it time to abandon warfarin and embrace oral direct thrombin inhibitors to prevent stroke in patients with atrial fibrillation?
Rahme RJ; Bernstein R; Batjer HH; Bendok BR
Neurosurgery; 2011 Feb; 68(2):N16-7. PubMed ID: 21654569
[No Abstract] [Full Text] [Related]
37. [Safety and efficacy of various modalities of antiplatelet prophylaxis of ischemic stroke in elderly patients with non-valvular atrial fibrillation].
Shevelev VI; Kanorsky SG
Klin Med (Mosk); 2012; 90(10):60-3. PubMed ID: 23285766
[TBL] [Abstract][Full Text] [Related]
38. [Dabigatran in the prevention of stroke in nonvalvular atrial fibrillation: complex clinical situations and real clinical practice].
Tkacheva ON; Akasheva DU
Ter Arkh; 2014; 86(4):103-7. PubMed ID: 24864477
[TBL] [Abstract][Full Text] [Related]
39. Transition from apixaban to warfarin--addressing excess stroke, systemic embolism, and major bleeding.
Cairns JA; Weitz JI
Am Heart J; 2015 Jan; 169(1):1-3. PubMed ID: 25497240
[No Abstract] [Full Text] [Related]
40. Dabigatran: will it change clinical practice?
Wartak SA; Bartholomew JR
Cleve Clin J Med; 2011 Oct; 78(10):657-64. PubMed ID: 21968472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
